Vivavision Biotech announced that its Phase IIa first-in-human trial of VVN539 Ophthalmic Solution in the US has met its primary study endpoints.

GameSquare Holdings and Swiss vision care startup Vivior have entered into a substantial multi-year partnership, aimed at fostering healthy digital habits, as per the official news release by the company.

Aviceda Therapeutics has kicked off its phase 2 SIGLEC trial, with the dosing of the first patient using AVD-104 for the treatment of geographic atrophy (GA).

Optos announced that it is enhancing the optomap ultra-widefield (UWF) retinal imaging capabilities of the California FA device. The aim is to provide greater support to eye care professionals in managing diseases and planning treatments.

TearRestore has recently revealed that their highly sought-after Thermal Mask and Eyelid Wipes will now be accessible at Walmart stores across the country, as well as on Walmart.com.

Rentschler Biopharma SE and Ikarovec have joined forces in a collaboration to develop AAV material for pre-clinical testing of Ikarovec's innovative gene therapy for geographic atrophy, an advanced stage of age-related macular degeneration.

Eye specialists, mathematicians, and game designers at the University of Southampton have collaborated to create and launch a smartphone app with the goal of enhancing crucial treatment for children diagnosed with amblyopia.

Prevent Blindness has once again declared June as Cataract Awareness Month to provide patients, care partners and professionals with information on topics related to types of cataract, risk factors, symptoms, and cataract surgery,.

Thea Pharma has recently launched the "Preservative Freedom Coalition," an initiative designed to raise awareness about unaddressed requirements in ocular surface disease and the potential for preservative-free topical ophthalmic medications.

Alimera Sciences has announced the successful completion of enrollment for the NEW DAY clinical trial. This randomized, controlled, multicenter study aims to generate prospective data on the effectiveness of Iluvien.